Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer: Trends and Underutilization in the National Cancer Database 2010-2022.
Journal: Practical radiation oncology
Published: September 08, 2025
Omission of Axillary Lymph Node Dissection in Patients with pT0-2 ER+/HER2- Breast Cancer with 3-5 Positive Lymph Nodes Undergoing Adjuvant Systemic Therapy and Radiation Does Not Impact Overall Survival: A National Cancer Database Analysis.
Journal: Annals of surgical oncology
Published: May 05, 2025
Solid basaloid adenoid cystic carcinoma of the breast: A high-grade triple negative breast carcinoma which rarely responds to neoadjuvant chemotherapy.
Journal: Human pathology
Published: February 11, 2025
hNIS-based imaging to monitor treatment with the novel oncolytic virus CF33-hNIS-antiPDL1 in humans with advanced triple negative breast cancer.
Journal: Frontiers in oncology
Published: January 22, 2025
An Observational Cohort Study Comparing Positive Margin Rates Using an Electromagnetic Navigational System Versus Wire Localization in Breast Conservation Surgery.
Journal: Annals of surgical oncology
Published: August 16, 2023
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study.
Journal: Therapeutic advances in medical oncology
Published: June 05, 2023
Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients.
Journal: Breast cancer research and treatment
Published: June 30, 2020
Prevalence of delta-like protein 3 expression in Merkel cell carcinoma.
Journal: Journal of the American Academy of Dermatology
Published: July 27, 2019
Omitting Completion Dissection in Melanoma? Help is Available for Surgeons Coping Without Routine Dissection, But More Work is Needed.
Journal: Annals of surgical oncology
Published: June 29, 2018
Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade.
Journal: Cancer immunology research
Published: July 27, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026